Prospective, randomised trial comparing fluids and dobutamine optimisation of oxygen delivery in high-risk surgical patients

ISRCTN ISRCTN42445141
DOI https://doi.org/10.1186/ISRCTN42445141
Secondary identifying numbers 2611/2002
Submission date
27/03/2006
Registration date
30/03/2006
Last edited
26/03/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Suzana Lobo
Scientific

Av Faria Lima 5416
Jardim Universitário
São José do Rio Preto
São Paulo
15091/000
Brazil

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesWe aimed to investigate the effect of oxygen delivery index (DO2I) optimisation with fluids versus with fluids and dobutamine on 60-day hospital mortality and incidence of complications.
Ethics approval(s)Ethics approval received from the local medical ethics board on the 13th May 2002 (ref: 2611/2002).
Health condition(s) or problem(s) studiedHigh-risk patients undergoing prolonged surgery
InterventionTherapy consisted of pulmonary artery catheter (PAC)-guided haemodynamic optimisation during the operation and 24 hours postoperatively, using either fluids alone or fluids and dobutamine with the aim of achieving supranormal values (oxygen delivery index [DO2I] greater than 600 ml/min/m^2).
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Dobutamine
Primary outcome measureTo evaluate the effect of both DO2I optimisation with fluids compared to with fluids and dobutamine on 60-day mortality in high-risk general surgery patients.
Secondary outcome measuresThe incidence of complications, particularly adverse cardiovascular events.
Overall study start date13/05/2002
Completion date31/05/2004

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants98
Key inclusion criteriaPatients older than 18 years old undergoing elective surgeries with greater than or equal to three points according to a risk scoring system adapted from the American College of Cardiology (ACC) or the American Heart Association (AHA) guidelines
Key exclusion criteria1. Refusal of consent
2. Haemodynamic instability prior to surgery
3. Congestive heart failure
4. Presence of infection
5. Acute myocardial ischaemia prior to enrolment
6. Life expectancy lower than 60 days
7. Disseminated malignancy
Date of first enrolment13/05/2002
Date of final enrolment31/05/2004

Locations

Countries of recruitment

  • Brazil

Study participating centre

Av Faria Lima 5416
São Paulo
15091/000
Brazil

Sponsor information

Faculty of Medicine of São José do Rio Preto (FAMERP) Foundation (Brazil)
Hospital/treatment centre

Av. Brigadeiro Faria Lima, 5416
Vila São Pedro
São Paulo
15091/000
Brazil

ROR logo "ROR" https://ror.org/052e6h087

Funders

Funder type

Hospital/treatment centre

Faculty of Medicine of Sao Jose do Rio Preto Foundation (Fundacao Faculdade de Medicina de Sao Jose do Rio Preto [FAMERP] - Hospital de Base) (Brazil)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 01/07/2006 Yes No